Skip to main
MVIS

MicroVision (MVIS) Stock Forecast & Price Target

MicroVision (MVIS) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Microvision is facing challenges in transitioning to commercialization, as evident from the sharp decline in its Q4 revenue and increase in net loss and adjusted EBITDA loss. However, the company has enhanced its balance sheet through issuing senior secured convertible notes and retains a significant amount of cash and investments, which may provide it with the necessary liquidity to fund operations. The upcoming acquisition and potential integration plans may offer more visibility into the company's potential for near-term commercial success.

Bears say

Microvision is facing significant challenges in translating their advanced lidar technology into meaningful revenue, as evidenced by their lower-than-expected sales and continued cash burn. While management is making efforts to expand their product portfolio and customer base through acquisitions, it remains to be seen if these moves will lead to sustainable revenue generation. The recent acquisition of lidar assets may improve their technology and positioning in the market, but profitability and operational efficiency are still major concerns.

MicroVision (MVIS) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of MicroVision and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About MicroVision (MVIS) Forecast

Analysts have given MicroVision (MVIS) a Strong Buy based on their latest research and market trends.

According to 2 analysts, MicroVision (MVIS) has a Strong Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

MicroVision (MVIS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.